Markers and determinants of progression of HIV-1 infection

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 5, 1998, Pages 406-409

  Phair, John P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032078246     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90140-8     Document Type: Review

References (35)

1. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4+ lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
2. Wei X, Ghosh S, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type-1 infection. Nature 1995;373:117-22.
3. Muñoz A, Sabin CA, Phillip AN. The incubation period of AIDS. AIDS 1997;11:369.
4. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within five years of infection with human immunodeficiency virus type-1. The Multicenter AIDS Cohort Study. J AIDS 1992;5:490-6.
5. Mellors J, Muñoz A, Giorgi J, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:949.
6. Kaslow R, Ostrow D, Detels R, et al. The Multicenter AIDS Cohort Study Rationale, organization and selected characteristics of the participants. Am J Epidemiol 1987;126: 310-8.
7. Detels R, English P, Visscher B, et al. Seroconversion, sexual activity and condom use among 2915 HIV seronegative men followed for up to two years. J AIDS 1989;2:77-83.
8. MacDonell K, Chmiel J, Poggensee L, et al. Predicting progression to AIDS. Combined usefulness of CD4+ lymphocyte counts and p24 antigenemia. Am J Med 1990;89:706.
9. Fahey J, Taylor J, Detels R, et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type-1. N Engl J Med 1990;322:166.
10. O'Brien T, Blattner W, Walters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105.
11. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
12. Schacker T, Collier A, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996;125:257-63.
13. Borrow P, Lewiski H, Hahn B, et al. Virus-specific CD8+ cytotoxic T-lymphocytes activity associated with control of viremia in primary human immunodeficiency virus type-1 infection. J Virol 1994;68:6103-10.
14. Moore JP, Cao Y, Ho DD, Koup RA. Development of anti-gp 120 antibody response during seroconversion to human immunodeficiency virus type-1. J Virol 1994;68:5142-55.
15. Panteleo G, Graziosi C, Fauci A. The immunopathogenesis of human immunodeficiency virus infections. N Engl J Med 1993;328:327-35.
16. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1 specific CD4+ T-cell responses associated with control of viremia. Science 1997;278:1447-50.
17. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;216:1179-81.
18. Wolinsky S, Wike C, Korber B, et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992;255:1134-7.
19. Wolinsky S, Korber B, Neumann A, et al. Adaptive evaluation of human immunodeficiency virus type-1 during the natural course of infection. Science 1996;272:537-42.
20. Kaslow R, Carrington N, Apple R, et al. Influence of combination of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996;2:405.
21. Dragic T, Litwin V Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:647-8.
22. Paxton W, Martin S, Tse D, et al. Relative resistance to HIV1 infection of CD4 lymphocyte from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Med 1996;2:412-7.
23. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:809-10.
24. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5,CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
25. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-8.
26. Roos MT, Lange JM, deGoede RE, et al. Viral phenotype and immune response in primary human immunodeficiency virus type-1 infection. J Infect Dis 1992;165:427-32.
27. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
28. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptor CCR3 and CCR5 facilitates infection by primary HIV-1 isolates. Cell 1996;85:1135-48.
29. Huang Y, Paxton WA, Wolinsky S, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240.
30. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856.
31. Smith MM, Dean M, Carrington C, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
32. Winkler C, Mode W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 1998;270:389-93.
33. Donovan RM, Bush C, Markowitz N, et al. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J Infect Dis 1996;174:401.
34. Gallette D, Weissman D, Jackson R, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271.
35. Hammer SM. Advances in antiretroviral therapy and viral load monitoring. AIDS 1996;10(suppl 3):S1-11.